![Innoplexus-DrD-partnership](https://www.innoplexus.com/wp-content/uploads/2022/04/Innoplexus-DrD-partnership-150x150.jpeg)
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 24
Apr 24
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreDer am 16.3.2018 in München gegründete KI-Bundesverband verfolgt das Ziel, Deutschland als attraktiven Wirtschaftsstandort für die Weiterentwicklung von KI zu etablieren und so seine internationale Wettbewerbsfähigkeit weiter zu stärken. In dem Verband mitwirken dürfen aufstrebende Unternehmen und Start-ups deren Geschäftsmodelle überwiegend auf KI basieren. Das Wohl des Menschen stehe bei den vom Bundesverband unterstützten KI …
Innoplexus AG wird Mitglied im Bundesverband für Künstliche Intelligenz (KI) Read More »
Innoplexus aims to democratize drug development with launch of new iPlexus Eschborn, Germany: Innoplexus AG announced today a groundbreaking update coming soon to their iPlexus platform that will leverage the power of blockchain technology and artificial intelligence to resolve inefficiencies in early-stage drug discovery. With an expected launch date of June 30, 2018, the new …
New Blockchain and AI-based Platform to Revolutionize Drug Discovery Read More »
Leader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ — Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the opening of Innoplexus Americas. This new affiliate will focus on empowering pharmaceutical companies in the United States and Latin America to achieve new …
Innoplexus Announces New North American Affiliate Helmed by Former Merck KGaA Executive Read More »
Eschborn, 5th May 2018 – Innoplexus AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by measuring the effect of its online and social media communication initiatives using its Artificial Intelligence (AI) based analysis technologies. Annually on May 5th, 20’000 hospitals across 177 countries participate in promoting hygiene standards worldwide. This …
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50 Finalist” for the prestigious TiE50 Awards Program recognizing the world’s most innovative tech startups. This awards competition is part of TiE Inflect 2018, the world’s largest conference for tech entrepreneurs. Innoplexus is helping organisations move …
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist Read More »
Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance & Management On June 18, 2018, the first annual AI summit jointly organised by Frankfurt School of Finance & Management and Innoplexus will take place at the campus of Frankfurt School. Among other activities, Frankfurt School …
Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can be repurposed and used for faster treatment of serious terminal illnesses. This is just one of the ways in which Innoplexus is harnessing the enormous power of data using Artificial Intelligence (AI), Machine Learning (ML) …
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …